Milan Laboratories (India) Private Limited, a active private limited company, was established on 26 March 2003 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2003PTC139736. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.98 Cr.
It upholds a compliant status. Employing 628 professional, Its leadership includes Rohini Rajeev Dongre (Director), Sharwari Upendra Deshpande (Director), Rahul Rajeev Dongre (Additional Director). Past directors included Upendra Madan Despande. It holds ₹70.39 Cr open charges and ₹79.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 303/304, 3Rd Floor, Odyssey It Park Wagle Estate, Midc, Thane(W), Thane, Maharashtra, 400604.
U24230MH2003PTC139736
139736
26 March 2003
₹2.00 Cr
₹1.98 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Milan Laboratories (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohini Rajeev Dongre | Director | 26 Mar 2003 | Current |
| Sharwari Upendra Deshpande | Director | 13 Mar 2025 | Current |
| Rahul Rajeev Dongre | Additional Director | 23 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Mar 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Milan Laboratories (India) Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 42.4% increase. The company also saw a substantial improvement in profitability, with a 24.85% increase in profit. The company's net worth Soared by an impressive increase of 22.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Milan Laboratories (India) had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹703,870,000.00
₹797,510,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2024 | Standard Chartered Bank | ₹10.00 Cr | Open |
| 11 Apr 2022 | Others | ₹20.00 Cr | Open |
| 02 Jan 2021 | Standard Chartered Bank | ₹1.00 Cr | Open |
| 02 Jan 2021 | Standard Chartered Bank | ₹5.00 Cr | Open |
| 18 Sep 2019 | Others | ₹12.20 Cr | Open |
Explore comprehensive loan charge details -
Milan Laboratories (India) has a workforce of 576 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Milan Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Milan Laboratories (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 01 Apr 2011 via Charge ID 10285507 with Tata Capital Limited was fully satisfied on 08 Sep 2025. was documented.
Progress on Rahul Rajeev Dongre was appointed as a Additional Director was appointed as a Additional Director on 23 May 2025 & has been associated with this company since 6 months 26 days . was documented.
Progress on Sharwari Upendra Deshpande was appointed as a Director was appointed as a Director on 13 Mar 2025 & has been associated with this company since 9 months 5 days . was documented.
The activity A charge registered on 25 Jan 2022 via Charge ID 100542691 with Others was fully satisfied on 17 Feb 2025. was completed.
The activity A charge registered on 08 Sep 2021 via Charge ID 100478192 with Standard Chartered Bank was fully satisfied on 17 Feb 2025. was completed.
The activity Milan Laboratories (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The CIN of Milan Laboratories (India) Private Limited is U24230MH2003PTC139736.
Milan Laboratories (India) Private Limited is headquartered at 303/304, 3Rd Floor, Odyssey It Park Wagle Estate, Midc, Thane(W), Thane, Maharashtra, 400604.
Milan Laboratories (India) Private Limited was incorporated on 26 March 2003.
The current directors of Milan Laboratories (India) Private Limited are
The primary industry of Milan Laboratories (India) Private Limited is Manufacturing.
Milan Laboratories (India) Private Limited is unlisted.
The authorized capital of Milan Laboratories (India) Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.98 Cr.
The compliance status of Milan Laboratories (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX